Imaging management and analysis services for ophthalmic clinical and preclinical studies
Total Trials
10
As Lead Sponsor
0
As Collaborator
Total Enrollment
1,265
NCT03839875
Evaluation of Efficacy and Safety of Gynomax® XL Ovule
Phase: Phase 4
Role: Collaborator
Start: Apr 3, 2019
Completion: Aug 9, 2019
NCT04330326
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease
Phase: Phase 2
Start: Jul 20, 2019
Completion: May 6, 2022
NCT06056947
Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule
Phase: Phase 3
Start: Jul 20, 2020
Completion: Aug 26, 2021
NCT04573153
Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients
Phase: Phase 2/3
Start: Sep 21, 2020
Completion: May 5, 2022
NCT04828564
Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19
Start: Apr 30, 2021
Completion: Dec 31, 2021
NCT05290987
Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing SARS-Cov-2 Viral Load.
Phase: N/A
Start: Jan 14, 2022
Completion: Nov 8, 2022
NCT05428202
Phase I Study of GN-037 Cream for Psoriasis
Phase: Phase 1
Start: Mar 28, 2022
Completion: Sep 30, 2022
NCT05361369
Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule
Start: May 9, 2022
Completion: Mar 15, 2023
NCT05443945
Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing Symptoms of Allergic Rhinitis
Start: Aug 30, 2022
Completion: Aug 14, 2023
NCT05706870
Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis
Start: Dec 7, 2022
Completion: Mar 3, 2024
Loading map...